查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2017200

注射包裝市場：按容器類型、容器材料、瓶蓋類型、劑型、填充量、最終用戶和應用分類－2026-2032年全球市場預測

Parenteral Products Packaging Market by Container Type, Container Material, Closure Type, Dosage Form, Fill Volume, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，注射劑包裝市場價值將達到 246.5 億美元，到 2026 年將成長至 268.3 億美元，到 2032 年將達到 479.7 億美元，複合年成長率為 9.97%。

主要市場統計數據
基準年 2025 246.5億美元
預計年份：2026年 268.3億美元
預測年份 2032 479.7億美元
複合年成長率 (%) 9.97%

本策略性介紹概述了為什麼注射劑產品的包裝對於整個現代治療產品組合的產品完整性、監管合規性和供應鏈彈性至關重要。

注射劑包裝涉及病患安全、無菌生產以及全球供應鏈的複雜性。本文旨在闡明為何該領域需要持續的策略關注。隨著治療方法發展為生物製藥、複方製劑和高敏感性製劑，包裝的功能已不再局限於簡單的密封，而是成為確保產品完整性、無菌性、低溫運輸相容性和以用戶為中心的給藥方式的關鍵要素。因此，參與藥物研發、契約製造和分銷的相關人員必須協調設計控制、法規遵循流程和籌資策略，以維持治療效果並降低污染風險。

評估近期美國關稅趨勢如何改變注射劑藥品包裝整個價值鏈的採購選擇、成本考量和近岸外包策略。

美國關稅和貿易政策調整為從世界各地採購包裝組件的公司帶來了新的成本、交貨時間和採購的考量。為了應對這些挑戰，採購團隊正在重新審視其供應商策略，透過提高在地採購率、協商包含保護性條款的長期合約以及審查關稅分類以確保HS編碼（協調制度）的準確應用來降低關稅風險。透過這些綜合措施，他們可以減少意外的關稅負擔並簡化海關程序。

詳細的細分洞察揭示了容器類型、材料、封蓋、劑型、填充量、使用環境和應用如何全面影響包裝決策和測試要求。

對細分市場的深入理解揭示了技術要求、採購優先順序和臨床應用案例的交匯點，以及它們如何影響包裝決策。根據容器類型，相關人員會評估每種配置（安瓿、袋裝、藥筒、注射器和管瓶）在劑量精度、與無菌填充線的兼容性以及患者給藥需求方面的優缺點。同時，也需要仔細考慮玻璃和塑膠容器材料之間的差異。 PET、聚丙烯和PVC等塑膠替代品在化學相容性、耐滅菌性和阻隔性方面各有優劣。這些材料的選擇必須兼顧監管要求和合格評定結果。

將美洲、歐洲、中東、非洲和亞太地區的供應鏈結構、法規結構和創新重點的差異進行區域比較。

區域趨勢對注射劑包裝的供應鏈結構、監管協調和創新重點有顯著影響。在美洲，製造商和加工商通常優先考慮產品上市速度、生產規模以及與當地監管機構的親和性，同時尋求區域夥伴關係關係以縮短供應鏈。該地區擁有成熟的醫藥產業叢集和先進的物流基礎設施，有利於高效分銷和嚴格的品質系統。

從企業層面深入了解供應商和製造商如何透過技術投資、整合服務和彈性夥伴關係模式來建立競爭優勢。

引領注射包裝生態系統的企業正透過在品質、自動化和材料科學方面的定向投資來脫穎而出，同時建立策略合作夥伴關係以彌補能力差距。注重封閉式填充和容器密封測試的供應商正在滿足客戶對確保無菌性的高期望。同時，致力於開發聚合物配方和表面處理技術以減少分層和萃取的公司正在高價值生物製藥應用領域獲得技術領先地位。

為行業領導者提供切實可行的建議，以加強整個注射劑藥品包裝業務的供應商合格、技術驗證、擴充性和永續性。

產業領導者可以透過整合跨職能部門的優先事項，制定面向未來的包裝策略，從而在創新與合藍圖之間取得平衡。首先，企業應優先考慮端到端的供應商資格認證，包括可審核的文件、材料檢驗協議和替代採購方案。協調品質、採購和法規遵循團隊可以降低供應中斷的風險，並加速糾正措施的實施。其次，投資於萃取物和洗脫液、容器和密封系統完整性以及人為因素的先進合格測試，可以降低上市風險，並支持監管申報。隨著治療方法從臨床應用過渡到商業化供應，這些技術投資將帶來顯著成效。

本報告概述了一種透明的調查方法，描述了定性研究、技術文獻和最佳實踐的綜合審查過程，這些內容構成了報告結論和建議的基礎。

本研究採用綜合分析方法，結合一手質性研究、實驗方案回顧和二手技術文獻，得出可操作的見解。一手研究包括與品質保證、法規和採購專家進行結構化訪談和研討會，以識別營運挑戰、供應商選擇標準和商業化限制因素。這些第一線專家的觀點與技術白皮書、法規指導文件以及關於材料適用性、容器和封蓋系統完整性以及包裝相關失效模式的同行評審研究進行交叉比對，以確保技術準確性。

該摘要概述了策略包裝決策如何影響整體治療方法的產品安全性、監管準備和供應鏈穩健性。

總之，注射劑包裝正從一個簡單的組成部分轉變為影響產品可行性、法規核准和供應連續性的策略領域。材料創新、監管對安全性和合規性的重視以及不斷變化的用戶需求，正在重新定義產品整個生命週期中的包裝要求。那些積極協調技術檢驗、供應商策略和營運投資的企業，更有能力降低風險，並在日益複雜的環境中實現差異化競爭優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按容器類型分類的注射劑藥品包裝市場

  • 安瓿
  • 包包
  • 墨水匣
  • 注射器
  • 管瓶

第9章：注射劑藥品包裝市場（依容器材料分類）

  • 玻璃
  • 塑膠
    • PET
    • 聚丙烯
    • PVC

第10章：注射劑包裝的市場關閉方法

  • 壓蓋
  • 翻蓋式帽
  • 橡膠塞
  • 螺帽

第11章 以劑型分類的注射包裝市場

  • 液體
    • 多次給藥
    • 單一劑量
  • 凍乾粉
    • 可複溶粉末
    • 無菌粉末

第12章：注射包裝市場（以灌裝量分類）

  • 1-5毫升
  • 5-10毫升
  • 超過10毫升
  • 少於1毫升

第13章 注射劑藥品包裝市場：依最終用戶分類

  • 門診治療
  • 診所
  • 居家照護
  • 醫院
  • 專科診所

第14章 注射劑藥品包裝市場：依應用領域分類

  • 糖尿病
  • 腫瘤學
  • 疫苗

第15章 注射劑藥品包裝市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 注射包裝市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 注射劑藥品包裝市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國注射藥品包裝市場

第19章：中國注射包裝市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Becton, Dickinson and Company
  • Corning Incorporated
  • Gerresheimer AG
  • Nipro Corporation
  • Schott AG
  • SGD Pharma SA
  • Shanghai Pharmaceutical Glass Co., Ltd.
  • Stevanato Group SpA
  • Tofflon Science and Technology Co., Ltd.
  • West Pharmaceutical Services, Inc.
  • Wipak Group
Product Code: MRR-035DA3C63703

The Parenteral Products Packaging Market was valued at USD 24.65 billion in 2025 and is projected to grow to USD 26.83 billion in 2026, with a CAGR of 9.97%, reaching USD 47.97 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 24.65 billion
Estimated Year [2026] USD 26.83 billion
Forecast Year [2032] USD 47.97 billion
CAGR (%) 9.97%

A strategic introduction that frames why parenteral product packaging now governs product integrity, regulatory compliance, and supply chain resilience across modern therapeutic portfolios

The packaging of parenteral products sits at the intersection of patient safety, sterile manufacturing, and global supply chain complexity, and the introduction frames why this domain demands continuous strategic attention. As therapies evolve toward biologics, combination products, and sensitive formulations, packaging has moved beyond containment to become an active enabler of product integrity, sterility assurance, cold chain compatibility, and user-centric dose delivery. Consequently, stakeholders across pharmaceutical development, contract manufacturing, and distribution must align design controls, regulatory pathways, and procurement strategies to preserve therapeutic performance and mitigate contamination risk.

Furthermore, an introduction to this landscape highlights the converging forces of regulatory tightening, material innovation, and customer expectations that compel organizations to revisit legacy packaging platforms. Transitioning from descriptive to prescriptive practice involves translating requirements into validated processes, adopting advanced secondary and tertiary protection measures, and investing in robust supplier qualification programs. In turn, these changes shape capital allocation, operational priorities, and cross-functional collaboration across quality, regulatory, and supply chain teams.

Recent transformative shifts within parenteral packaging reflect a rapid realignment of priorities that extend from raw material sourcing to final dose delivery, catalyzed by technological, regulatory, and commercial drivers. Notably, material science advances have accelerated adoption of polymeric alternatives and engineered glass formulations that reduce delamination risk and improve breakage resistance. At the same time, the industry is experiencing a surge in demand for user-friendly delivery systems and compact formats that support ambulatory and home care administration, prompting suppliers and developers to re-evaluate container geometries, closure interfaces, and compatibility testing.

Transitioning toward more resilient supply networks, manufacturers increasingly pursue supplier diversification and regional sourcing, reducing single-source dependencies that previously contributed to disruption. In parallel, regulatory agencies are emphasizing human factors, extractables and leachables, and container closure integrity testing, which together raise the technical bar for packaging qualification. Consequently, companies investing in automation, closed-system filling, and stringent environmental controls are gaining operational advantages. These cumulative shifts are driving a more integrated view of packaging as a cross-disciplinary enabler of product safety, patient experience, and commercial differentiation.

Assessment of how recent United States tariff dynamics are altering sourcing choices, cost considerations, and nearshoring strategies across the parenteral packaging value chain

The imposition of tariffs and trade policy adjustments originating from the United States has introduced a new layer of cost, timing, and sourcing considerations for organizations that depend on globally sourced packaging components. In response, procurement teams are recalibrating supplier strategies to mitigate tariff exposure by increasing local sourcing, negotiating longer-term contracts with protective terms, and engaging in tariff classification reviews to ensure accurate harmonized system coding. These measures, taken together, help reduce unexpected duty liabilities and enable smoother customs interactions.

Moreover, tariffs have encouraged some manufacturers to localize critical production steps or enter strategic partnerships with regional converters to preserve price competitiveness and reduce lead times. While supply chain reshoring can enhance responsiveness, it also necessitates investment in quality systems and compliance capabilities in new geographies. Consequently, regulatory alignment, workforce training, and capital investment are essential to realize the operational benefits of nearshoring. Ultimately, the cumulative impact of tariff dynamics compels a more holistic cost-to-serve analysis that weighs duty exposure against inventory, lead time, and regulatory conformity.

Detailed segmentation insights revealing how container types, materials, closures, dosage forms, fill volumes, user settings, and applications collectively dictate packaging decisions and testing needs

A nuanced understanding of segmentation reveals where technical requirements, procurement priorities, and clinical use cases intersect to drive packaging decisions. Based on container type, stakeholders evaluate tradeoffs among ampoule, bag, cartridge, syringe, and vial configurations with respect to dosing accuracy, aseptic fill line compatibility, and patient administration needs. In tandem, container material distinctions between glass and plastic require careful consideration; plastic alternatives such as PET, polypropylene, and PVC present diverse benefits and challenges in chemical compatibility, sterilization tolerance, and barrier properties. These material selections must be balanced against regulatory expectations and compatibility testing outcomes.

Closures also play a pivotal role; crimp caps, flip-off caps, rubber stoppers, and screw caps each introduce distinct integrity profiles and aseptic handling requirements, which in turn affect closure selection for specific formulations and fill lines. The dosage form further stratifies packaging approaches as liquid preparations and lyophilized powder demand different containment and reconstitution strategies. Liquid presentations may be designed for multi-dose or single-dose use, while lyophilized powders appear as reconstitutable powder or sterile powder, each imposing unique container closure integrity criteria and reconstitution compatibility. Fill volume categories ranging from up to 1 milliliter through 1 to 5 milliliters, 5 to 10 milliliters, and above 10 milliliters influence fill accuracy, vial geometry, and secondary packaging dimensions. Finally, the end user environment-spanning ambulatory care, clinic, home care, hospital, and specialty clinics-shapes decisions around ease of use, dosing safety features, and portability. Application-specific demands for diabetes, oncology, and vaccines create additional layers of technical and regulatory requirements, which ultimately guide the selection and validation of integrated packaging systems.

Comparative regional perspectives on how supply chain structure, regulatory frameworks, and innovation priorities differ across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics exert powerful influence on supply chain configuration, regulatory alignment, and innovation priorities across parenteral packaging. In the Americas, manufacturers and converters often prioritize speed to market, scale manufacturing capability, and regulatory familiarity with local agencies, while also exploring regional partnerships to shorten supply lines. This region's combination of established pharmaceutical clusters and advanced logistics infrastructure supports a focus on efficient distribution and rigorous quality systems.

In Europe, the Middle East & Africa, regulatory complexity and cross-border trade rules encourage harmonized testing protocols and a strong emphasis on sustainability and circularity in packaging decisions. Suppliers in this region increasingly respond to regulatory emphasis on environmental impact by developing recyclable or reduced-material solutions. Meanwhile, in the Asia-Pacific market, rapid capacity expansion, cost-competitive manufacturing, and accelerating adoption of biologics drive demand for scalable sterile filling, contract manufacturing, and high-volume component production. Across regions, transitional themes such as supplier diversification, regional qualification programs, and alignment of quality management systems underscore the need for multinational organizations to adopt flexible sourcing and compliance strategies that are appropriate for local regulatory environments.

Key company-level insights into how suppliers and manufacturers are building competitive advantage through technical investment, integrated services, and resilient partnership models

Leading organizations across the parenteral packaging ecosystem are differentiating through targeted investments in quality, automation, and materials science while forging strategic collaborations to address capability gaps. Suppliers that emphasize closed-system filling and container closure integrity testing are meeting heightened customer expectations for sterility assurance. Concurrently, companies that develop polymer formulations or surface treatments to mitigate delamination and extractables are gaining technical leadership in high-value biologic applications.

Partnership models are evolving; contract manufacturers and component suppliers increasingly offer integrated services that bundle design support, regulatory documentation assistance, and stability testing to shorten development timelines. At the same time, procurement teams are placing greater emphasis on supplier transparency, track-and-trace capabilities, and dual-sourcing arrangements to preserve continuity of supply. Collectively, these behaviors indicate an industry moving toward collaborative value chains where technical competence, regulatory readiness, and operational resilience determine competitive advantage.

Actionable recommendations for industry leaders to strengthen supplier qualification, technical validation, scalability, and sustainability across parenteral packaging operations

Industry leaders can take decisive actions to future-proof packaging strategies by integrating cross-functional priorities into a coherent roadmap that balances innovation with compliance. First, organizations should prioritize end-to-end supplier qualification that includes audit-ready documentation, material verification protocols, and contingency sourcing plans; aligning quality, procurement, and regulatory teams reduces the risk of supply interruptions and expedites corrective actions. Second, investment in enhanced compatibility testing for extractables and leachables, container closure integrity, and human factors will de-risk product launches and support regulatory submissions. These technical investments pay dividends when therapies move from clinical stages to commercial supply.

In addition, companies should pursue design-for-manufacturability practices that shorten fill-finish validation cycles and adopt modular automation to scale production efficiently. Firms must also consider sustainability pathways, such as material-lightening, recyclable components, and energy-efficient processes, to meet stakeholder expectations and regulatory trends. Finally, leaders should cultivate strategic partnerships with converters and contract manufacturers that offer co-development capabilities and flexible regional footprints; this approach enables faster response to policy shifts, tariffs, or demand variability while preserving compliance and quality.

Transparent research methodology explaining the integrated qualitative, technical literature, and best-practice review process that underpins the report's conclusions and recommendations

This research synthesis is grounded in a multi-method approach that integrates primary qualitative inquiry, laboratory protocol review, and secondary technical literature to produce actionable insights. Primary engagement included structured interviews and workshops with quality assurance, regulatory, and procurement professionals to surface operational challenges, supplier selection criteria, and commercialization constraints. These firsthand perspectives were triangulated with technical whitepapers, regulatory guidance documents, and peer-reviewed studies on materials compatibility, container closure integrity, and packaging-related failure modes to ensure technical accuracy.

Complementing stakeholder interviews, a systematic review of industry best practices and case studies informed recommendations around supplier diversification, automation adoption, and testing strategies. Throughout the analysis, methodological rigor was maintained by documenting inclusion criteria for sources, applying reproducible evaluation frameworks to qualitative inputs, and cross-validating conclusions against established regulatory expectations. As a result, the methodology supports robust, defensible insights while remaining adaptable to client-specific inquiries and deeper quantitative investigation when required.

Concluding synthesis that encapsulates how strategic packaging decisions now determine product safety, regulatory readiness, and supply chain robustness across modern therapies

In conclusion, parenteral product packaging is transitioning from a component-centric function to a strategic domain that shapes product viability, regulatory success, and supply continuity. Material innovation, regulatory emphasis on safety and compatibility, and evolving user needs are collectively redefining packaging requirements across the product lifecycle. Organizations that proactively align technical validation, supplier strategy, and operational investments position themselves to mitigate risk and unlock competitive differentiation in an increasingly complex environment.

Looking ahead, the most resilient stakeholders will be those that adopt cross-disciplinary governance, prioritize supplier transparency, and invest in automation and testing capabilities that anticipate regulatory scrutiny. By integrating the recommendations and insights presented, decision-makers can better navigate trade policy shifts, regional variations, and the technical demands of advanced therapies, ensuring packaging decisions are both scientifically sound and operationally sustainable.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Parenteral Products Packaging Market, by Container Type

  • 8.1. Ampoule
  • 8.2. Bag
  • 8.3. Cartridge
  • 8.4. Syringe
  • 8.5. Vial

9. Parenteral Products Packaging Market, by Container Material

  • 9.1. Glass
  • 9.2. Plastic
    • 9.2.1. Pet
    • 9.2.2. Polypropylene
    • 9.2.3. Pvc

10. Parenteral Products Packaging Market, by Closure Type

  • 10.1. Crimp Cap
  • 10.2. Flip Off Cap
  • 10.3. Rubber Stopper
  • 10.4. Screw Cap

11. Parenteral Products Packaging Market, by Dosage Form

  • 11.1. Liquid
    • 11.1.1. Multi Dose
    • 11.1.2. Single Dose
  • 11.2. Lyophilized Powder
    • 11.2.1. Reconstitutable Powder
    • 11.2.2. Sterile Powder

12. Parenteral Products Packaging Market, by Fill Volume

  • 12.1. 1 To 5 Milliliters
  • 12.2. 5 To 10 Milliliters
  • 12.3. Above 10 Milliliters
  • 12.4. Up To 1 Milliliter

13. Parenteral Products Packaging Market, by End User

  • 13.1. Ambulatory Care
  • 13.2. Clinic
  • 13.3. Home Care
  • 13.4. Hospital
  • 13.5. Specialty Clinics

14. Parenteral Products Packaging Market, by Application

  • 14.1. Diabetes
  • 14.2. Oncology
  • 14.3. Vaccines

15. Parenteral Products Packaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Parenteral Products Packaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Parenteral Products Packaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Parenteral Products Packaging Market

19. China Parenteral Products Packaging Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Becton, Dickinson and Company
  • 20.6. Corning Incorporated
  • 20.7. Gerresheimer AG
  • 20.8. Nipro Corporation
  • 20.9. Schott AG
  • 20.10. SGD Pharma SA
  • 20.11. Shanghai Pharmaceutical Glass Co., Ltd.
  • 20.12. Stevanato Group S.p.A.
  • 20.13. Tofflon Science and Technology Co., Ltd.
  • 20.14. West Pharmaceutical Services, Inc.
  • 20.15. Wipak Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 213. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 215. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 216. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 217. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 218. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 245. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 246. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 248. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 249. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 251. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 257. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 259. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 260. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 261. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 262. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)